from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0948c/-

LFCtreatmentdescriptionclass of inhibitor

0.040

Amikacinug/mL Amikacintranslation

1.072

Cap5-10ug/mL Capreomycintranslation

3.074

Rox10-50 ug/mL Roxithromycintranslation

1.267

SM2-5 ug/mL Streptomycintranslation

-0.197

Tet5-10 ug/mL Tetracyclinetranslation

0.676

Rif0.2-5ug/mL Rifampicintranscription

-0.124

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.774

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.075

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.127

CPZ10-50 ug/mL Chlorpromazinerespiration

0.008

Clofazimine10-13 ug/mL Clofaziminerespiration

0.224

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-3.211

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.424

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.783

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.259

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.034

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.111

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.333

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.545

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.988

KCN5-20 ug/mL Potassium cyaniderespiration

-0.478

NaN30.2-2 mM Sodium aziderespiration

2.208

Nigericin50 uM Nigericinrespiration

-0.640

TRC10-150 ug/mL Triclosanrespiration

0.278

TRZ10-25 ug/mL Thioridazinerespiration

0.713

Valinomycin0.5-10 uM Valinomycinrespiration

1.082

ZnSO42 mM ZnSO4respiration

-0.072

menadione6-10 ug/mL Menadionerespiration

-0.189

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.087

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.112

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.273

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.607

NRP_1Non-replicating persistence stage 1dosRassociated

0.183

Amp0.2mg/mL AmpicillincellWall

-0.249

Cephalexin20-100 ug/mL CephalexincellWall

0.474

Cerulenin0.32-5 ug/mL CerulenincellWall

0.150

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.049

EMB10-20 ug/mL EthambutolcellWall

-0.355

Eta12-40 ug/mL EthionamidecellWall

-0.044

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.366

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.107

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.191

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.459

BZA0.12 mg/mL BenzamidearomaticAmides

0.360

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.213

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.123

H2O24 mM hydrogen peroxideDNAdamaging

0.030

Levo10 ug/mL LevofloxacinDNAdamaging

0.303

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.333

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.037

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.519

UVUV-irradiationDNAdamaging

-0.643

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.010

Antimycin12.5-50 ug/mL Antimycin A?

-0.313

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.385

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.464

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.392

PA8240.2-2 ug/mL PA-824?

-1.508

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.173

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.781

Verapamil50 uM Verapamil?

0.427

mercaptoethanol2 mM 2-Mercaptoethanol?

0.044

methoxatin10-20 ug/mL Methoxatin?